Journal article icon

Journal article

The future of vaccines for tuberculosis

Abstract:

Exciting clinical results from 2 clinical TB vaccine trials were published in 2018. These, plus promising preclinical candidates form a healthy pipeline of potential vaccines against the leading cause of death from a single infectious agent. The only licensed vaccine, the BCG, continues to be an important tool in protecting against severe forms of TB in children, but has not stopped the diseases causing 1.3 million deaths per year. This review provides an overview of the current TB vaccine pi...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1016/j.ccm.2019.07.009

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Paediatrics
Department:
Unknown
Role:
Author
Publisher:
Elsevier Publisher's website
Journal:
Clinics in Chest Medicine Journal website
Volume:
40
Issue:
4
Pages:
849-856
Publication date:
2019-11-12
DOI:
EISSN:
1557-8216
ISSN:
0272-5231
Source identifiers:
1072832
Keywords:
Pubs id:
pubs:1072832
UUID:
uuid:368af149-fc33-4c24-93fc-62d9c232ab1c
Local pid:
pubs:1072832
Deposit date:
2019-12-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP